Hoarseness or changes in voice (dysphonia) is a recognized symptom that can occur with amyloidosis when it affects the larynx. This commonly happens because amyloidosis can impact the glottis, which is where your vocal cords are located. If you're experiencing hoarseness, it's important to discuss this symptom with your Show Full Answer
Hoarseness or changes in voice (dysphonia) is a recognized symptom that can occur with amyloidosis when it affects the larynx. This commonly happens because amyloidosis can impact the glottis, which is where your vocal cords are located. If you're experiencing hoarseness, it's important to discuss this symptom with your healthcare team. Regarding your medications, Tafamidis (Vyndaqel/Vyndamax) is specifically FDA-approved for ATTR cardiomyopathy and works as a TTR stabilizer. While waiting for approval, continue taking your prescribed medications as directed by your doctor, but make sure to report any new symptoms like the hoarseness you're experiencing.
May 8, 2025